Introduction of Extraterritorial Practices of Medical Institution PPPs
In recent years, the Chinese government has been dedicated to the reform of state-owned hospitals and has issued a series of policy papers in this field, including Opinions of the State Council on Deepening Medicine and Health System Reform issued by the State Council in 2009, Opinions of the National Development and Reform Commission, the Ministry of Health and Other Departments on Further Encouraging and Guiding Social Capital to Establish Medical Institutions promulgated in 2010, and Circular of the General Office of the State Council on Progressing the Guiding Opinions of the Ministry of Finance, the National Development and Reform Commission and the People's Bank of China on Promoting the Public-Private-Partnership (PPP) Mechanism in Public Services (“the Guiding Opinions”) published in 2015. Particularly in the Guiding Opinions, the government promotes the development of non-public medical institutions, and specifically encourages social capital participation through the public-private-partnership (PPP) mechanism for public services including medical treatment, and healthcare. This makes a big contribution to the prospects of system innovation in the healthcare sector. In this context, it is essential to broaden the international perspective, and to seek valuable experience and innovative ideas from health sector developments in other countries.
|文章标题||Introduction of Extraterritorial Practices of Medical Institution PPPs|
- ·Introduction of Extraterritorial Practices of Medical Institution PPPs
- ·The Drug Marketing Authorization Holder Mechanism: Moving Forward through Exploration
- ·China Eases Restrictions on Foreign Ownership of Chinese FIs
- ·Application of Law in Anti-commercial Bribery in Medical Field
- ·Does the 24-month Medical Treatment Period Apply Directly to Employees?
- ·China’s M.I.I.T. Proposes Broad Regulatory Oversight over Pre-Installed Mobile Phone/Device Applications
- ·Hong Kong’s competition law now in force – Tips for financial institutions
- ·Hong Kong Competition Commission’s enforcement and leniency policies
- ·A new cross border financing management regime implemented in China’s four free trade zones
- ·First Boycott Decision: Be Careful with Concerted Exclusive Dealing
- ·The Antitrust Safe Harbor for Exercising IPRs: More Details are Needed for its Scope, Thresholds and Compatibility
- ·Qualified foreign institutional investors investing in China’s Inter-bank Bond Market are no longer subject to approval and quota restrictions
- ·Highlights of Recent Legislation in connection with China’s Anti-monopoly Law
- ·What has been “Changed” and “Unchanged” for the foreign investments in online publishing? -- A capsule review on the online publishing service rules
- ·The Employment of “Elderly” Foreigners in China: Service or Employment?